semler scientific, inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care. semler closed the initial public offering of its common stock on february 26, 2014 and its common stock is now listed under the ticker symbol "smlr." additional information about semler can be found at www.semlerscientific.com.
Company profile
Ticker
SMLR
Exchange
Website
CEO
Douglas Murphy-Chutorian
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
SMLR stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
6 Mar 24
8-K
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
5 Mar 24
8-K
Other Events
22 Jan 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
9 Nov 23
8-K
Departure of Directors or Certain Officers
23 Oct 23
ARS
2022 FY
Annual report to shareholders
8 Sep 23
DEF 14A
Definitive proxy
8 Sep 23
PRE 14A
Preliminary proxy
29 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
Transcripts
SMLR
Earnings call transcript
2023 Q4
5 Mar 24
SMLR
Earnings call transcript
2023 Q3
9 Nov 23
SMLR
Earnings call transcript
2023 Q2
11 Aug 23
SMLR
Earnings call transcript
2023 Q1
10 May 23
SMLR
Earnings call transcript
2022 Q4
21 Mar 23
SMLR
Earnings call transcript
2022 Q3
2 Nov 22
SMLR
Earnings call transcript
2022 Q2
3 Aug 22
SMLR
Earnings call transcript
2022 Q1
3 May 22
SMLR
Earnings call transcript
2021 Q4
1 Mar 22
SMLR
Earnings call transcript
2021 Q3
2 Nov 21
Latest ownership filings
SC 13G/A
Topline Capital Management, LLC
12 Feb 24
SC 13G/A
AltraVue Capital, LLC
26 Jan 24
SC 13D/A
SEMLER ERIC
14 Sep 23
4
ERIC SEMLER
13 Sep 23
4
Renae Cormier
13 Jul 23
3
Renae Cormier
13 Jul 23
4
DANIEL S MESSINA
2 Jun 23
4
Douglas Murphy-Chutorian
17 May 23
SC 13D/A
Murphy-Chutorian Douglas
17 May 23
3
ERIC SEMLER
20 Apr 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 37.50 mm | 37.50 mm | 37.50 mm | 37.50 mm | 37.50 mm | 37.50 mm |
Cash burn (monthly) | 666.00 k | 669.92 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 3.98 mm | 4.01 mm | n/a | n/a | n/a | n/a |
Cash remaining | 33.51 mm | 33.49 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 50.3 | 50.0 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
63.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 84 |
Opened positions | 11 |
Closed positions | 11 |
Increased positions | 27 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 79.04 bn |
Total shares | 4.49 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Cerity Partners | 700.55 k | $17.77 bn |
William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 | 641.99 k | $16.11 mm |
Topline Capital Management | 399.86 k | $8.97 mm |
Vanguard | 327.84 k | $8.32 bn |
BLK Blackrock | 316.87 k | $8.04 bn |
LSV Asset Management | 144.55 k | $3.67 mm |
CI Private Wealth | 124.17 k | $3.15 bn |
AltraVue Capital | 122.00 k | $3.10 bn |
D. E. Shaw & Co. | 111.81 k | $2.84 bn |
Geode Capital Management | 105.35 k | $2.67 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Sep 23 | Semler Eric | Common Stock, $0.001 par value | Buy | Acquire P | Yes | No | 28.11 | 26,868 | 755.26 k | 77,771 |
12 Sep 23 | Semler Eric | Common Stock, $0.001 par value | Buy | Acquire P | Yes | No | 27.7 | 25,903 | 717.51 k | 50,903 |
11 Sep 23 | Semler Eric | Common Stock, $0.001 par value | Buy | Acquire P | Yes | No | 26.98 | 25,000 | 674.50 k | 25,000 |
10 Jul 23 | Renae Cormier | Stock Option Common Stock | Grant | Acquire A | No | No | 25.47 | 5,000 | 127.35 k | 5,000 |
31 May 23 | Daniel S Messina | Common Stock | Grant | Acquire A | No | No | 0 | 909 | 0.00 | 8,410 |
16 May 23 | Murphy-Chutorian Douglas | Common Stock Warrant (right to buy Common Stock | Sale back to company | Dispose D | Yes | No | 25.24 | 60,000 | 1.51 mm | 0 |
16 May 23 | Murphy-Chutorian Douglas | Common Stock Warrant Common Stock | Sale back to company | Dispose D | Yes | No | 25.74 | 16,875 | 434.36 k | 0 |
News
12 Health Care Stocks Moving In Tuesday's Intraday Session
5 Mar 24
Earnings Scheduled For March 5, 2024
5 Mar 24
Semler Scientific's Earnings: A Preview
4 Mar 24
Semler Scientific Plans To Seek New 510(K) Clearance From FDA For Expanded Use Of QuantaFlo Following Correspondence With FDA - Filing
22 Jan 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
10 Jan 24